Brind.
  1. Martin Brenner has taken on the role of CEO and CSO of iBio, Inc., where he is leading a collaboration with AstralBio focused on target discovery.

Marshall Wace participated in iBio's public offering on August 25, 2025.

1 report, 1 independent Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Marshall Wace participated in iBio's public offering on August 25, 2025.

Who's involved

What this event is mainly about
Marshall Wace

Keep exploring

Part of

Martin Brenner has taken on the role of CEO and CSO of iBio, Inc., where he is leading a collaboration with AstralBio focused on target discovery. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireiBio Announces Closing of $50 Million Public Offering Total gross proceeds of $100 million if all Series G warrants and Series H warrants are exercised for cash Financing was led by Balyasny Asset Ma